NYSE: MTD · Diagnostics & Research
Mettler-Toledo International (MTD) fair value: undervalued or overvalued?
As of 2 Oct 2026, Faircurve's model values Mettler-Toledo International (MTD) at $1,422.10 a share. The stock last closed at $1,486.19, which puts the model's fair value 4.3% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 2 Oct 2026. Mettler-Toledo International Inc.
Faircurve Insights · 2 Oct 2026
Mettler-Toledo International Inc. is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S.
Faircurve's model valued Mettler-Toledo International Inc. at $1,422.10 a share on 2 Oct 2026. This is the midpoint of 2,000 simulations. The previous run, on 26 Sep 2026, gave $1,451.83, so the fair value moved -2.0%. The calibrated range over 63 trading days is $1,193.11 to $1,733.99, built from the fair value, since there is no live options data for the stock. Ranges built this way held the price 60% of the time at this horizon. The model's evidence grade for the valuation is High.
The overall quality score for the business is 63 out of 100 against comparable companies. The model compares it with Quest Diagnostics Incorporated, Illumina, Inc., IDEXX Laboratories, Inc., Waters Corporation, IQVIA Holdings Inc., Agilent Technologies, Inc., and Medpace Holdings, Inc. Around its last 8 earnings reports, the stock moved +2.0%, -15.3%, -1.2%, 0.0%, -5.4%, +2.7%, +1.9%, and -11.4%.
Written from the figures on this page for the 2 Oct 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give MTD?
The calibrated range for MTD over 63 trading days is $1,193.11 to $1,733.99. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $1,187.36 to $1,679.41. In 42% of the simulations the fair value came out above the price the model ran on.
How does MTD score on business quality?
Mettler-Toledo International's overall quality score is 63 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 96 | 46.7%ROIC | 9.3% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 31 | 0.95xFCF / net income | 1.24x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analyst estimate revisions. | 35 | 4.0%Revenue growth, trailing | 6.3% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 68 | 2.6%Net buybacks / market value | 1.8% |
| Balance sheetNet debt to EBITDA and interest coverage. | 52 | 1.58xNet debt / EBITDA | 0.96x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 91 | 0.7 ptsEBITDA margin downside volatility, 5y | 1.4 pts |
How does MTD compare with similar companies?
The companies in diagnostics & research closest to Mettler-Toledo International in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| DGX Quest Diagnostics Incorporated | $233.33 | $280.88 | +20.4% | Undervalued |
| LH Labcorp Holdings Inc. | $308.49 | $303.65 | -1.6% | Low evidence grade |
| ILMN Illumina, Inc. | $273.04 | $208.21 | -23.7% | Overvalued |
| IDXX IDEXX Laboratories, Inc. | $518.39 | $486.42 | -6.2% | Fairly valued |
| WAT Waters Corporation | $425.21 | $329.03 | -22.6% | Overvalued |
| IQV IQVIA Holdings Inc. | $258.21 | $359.38 | +39.2% | Undervalued |
| A Agilent Technologies, Inc. | $167.78 | $161.23 | -3.9% | Fairly valued |
| MEDP Medpace Holdings, Inc. | $599.47 | $680.99 | +13.6% | Fairly valued |
All diagnostics & research stocks ranked by gap to fair value
When does MTD report earnings, and how has the stock reacted?
Mettler-Toledo International's next earnings report is scheduled for 5 Nov 2026. Companies can move their dates.
Options prices on 2 Oct 2026 imply a move of about 3.8% in either direction through the nearest expiry, about 13 days out. That is the size the market is pricing, not a direction.
How MTD moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 2.4%.
| Report date | Two session move |
|---|---|
| 30 Jul 2026 | +2.0% |
| 7 May 2026 | -15.3% |
| 5 Feb 2026 | -1.2% |
| 6 Nov 2025 | 0.0% |
| 31 Jul 2025 | -5.4% |
| 1 May 2025 | +2.7% |
| 6 Feb 2025 | +1.9% |
| 8 Nov 2024 | -11.4% |
Mettler-Toledo International at a glance
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S.
- Market value
- $30.5B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Revenue expected, next twelve months
- $4.4B
- Consensus revenue growth, next fiscal year
- +5.3%
- Analysts with estimates
- 8
- Beta to the US market
- 0.69
- First valued by Faircurve
- 1 May 2026
How the fair value is worked out: the model prices Mettler-Toledo International on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 26 Sep 2026 the model's fair value for MTD was $1,451.83. As of 2 Oct 2026 it is $1,422.10, a change of -2.0%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Mettler-Toledo International's valuation
Is Mettler-Toledo International stock undervalued or overvalued?
On Faircurve's model, MTD reads as Fairly valued as of 2 Oct 2026. The model's fair value is $1,422.10 a share against a last close of $1,486.19, a gap of -4.3%.
What is MTD's fair value?
$1,422.10 a share as of 2 Oct 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $1,187.36 to $1,679.41.
What price range does the model give MTD?
$1,193.11 to $1,733.99 over 63 trading days. Ranges built this way held the price 60% of the time across 4,327 past valuations, refreshed 26 Sep 2026.
When does Mettler-Toledo International report earnings next?
The next report is scheduled for 5 Nov 2026. Companies can move their dates.
How much has MTD moved on past earnings reports?
Across its last 8 reports the median two session move was 2.4%, ignoring direction. The largest was -15.3% around the report of 7 May 2026.
How confident is the model in this valuation?
The model's evidence grade for MTD is high. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.